Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - ELEC
LB  - 1.
AU  - International Osteoporosis Foundation
J2  - What Is Osteoporosis?
ER  - 
TY  - ELEC
LB  - 2.
AU  - National Institute for Health and Care Excellence
J2  - Bisphosphonates for Treating Osteoporosis
PY  - 2017
ER  - 
TY  - JOUR
LB  - 3.
AU  - Freemantle, N
AU  - Cooper, C
AU  - Diez-Perez, A
AU  - Gitlin, M
AU  - Radcliffe, H
AU  - Shepherd, S
AU  - Roux, C
TI  -  Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
J2  - Osteoporos Int
SP  - 209
PY  - 2013
VL  - 24
SP  - 209
ER  - 
TY  - JOUR
LB  - 4.
AU  - Saito, T
AU  - Sterbenz, JM
AU  - Malay, S
AU  - Zhong, L
AU  - MacEachern, MP
AU  - Chung, KC
TI  -  Effectiveness of antiosteoporotic drugs to prevent secondary fragility fractures: systematic review and metaanalysis
J2  - Osteoporos Int
SP  - 3289
PY  - 2017
VL  - 28
SP  - 3289
ER  - 
TY  - JOUR
LB  - 5.
AU  - Compston, J
AU  - Cooper, A
AU  - Cooper, C
AU  - Gittoes, N
AU  - Gregson, C
AU  - Harvey, N
TI  -  UK clinical guideline for the prevention and treatment of osteoporosis
J2  - Arch Osteoporos
SP  - 43
PY  - 2017
VL  - 12
SP  - 43
ER  - 
TY  - ELEC
LB  - 6.
AU  - Electronic Medicines Compendium
ER  - 
TY  - JOUR
LB  - 7.
AU  - Hawley, S
AU  - Javaid, MK
AU  - Rubin, KH
AU  - Judge, A
AU  - Arden, NK
AU  - Vestergaard, P
TI  -  Incidence and predictors of multiple fractures despite high adherence to oral bisphosphonates: a binational population-based Cohort study
J2  - J Bone Miner Res
SP  - 234
PY  - 2016
VL  - 31
SP  - 234
ER  - 
TY  - JOUR
LB  - 8.
AU  - Dugard, MN
AU  - Jones, TJ
AU  - Davie, MW
TI  -  Uptake of treatment for osteoporosis and compliance after bone density measurement in the community
J2  - J Epidemiol Community Health
SP  - 518
PY  - 2010
VL  - 64
SP  - 518
ER  - 
TY  - JOUR
LB  - 9.
AU  - Silverman, SL
AU  - Schousboe, JT
AU  - Gold, DT
TI  -  Oral bisphosphonate compliance and persistence: a matter of choice?
J2  - Osteoporos Int
SP  - 21
PY  - 2011
VL  - 22
SP  - 21
ER  - 
TY  - report
LB  - 10.
AU  - International Osteoporosis Foundation
J2  - The Adherence Gap: Why Osteoporosis Patients Don’t Continue with Treatment
PY  - 2005
ER  - 
TY  - JOUR
LB  - 11.
AU  - Siris, ES
AU  - Gehlbach, S
AU  - Adachi, JD
AU  - Boonen, S
AU  - Chapurlat, RD
AU  - Compston, JE
TI  -  Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)
J2  - Osteoporos Int
SP  - 27
PY  - 2011
VL  - 22
SP  - 27
ER  - 
TY  - JOUR
LB  - 12.
AU  - Roh, YH
AU  - Koh, YD
AU  - Noh, JH
AU  - Gong, HS
AU  - Baek, GH
TI  -  Effect of health literacy on adherence to osteoporosis treatment among patients with distal radius fracture
J2  - Arch Osteoporos
SP  - 42
PY  - 2012
VL  - 12
SP  - 42
ER  - 
TY  - JOUR
LB  - 13.
AU  - Modi, A
AU  - Fan, CS
AU  - Tang, J
AU  - Weaver, JP
AU  - Sajjan, S
TI  -  Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: an observational study
J2  - Bone Rep
SP  - 208
PY  - 2016
VL  - 5
SP  - 208
ER  - 
TY  - JOUR
LB  - 14.
AU  - Raybould, G
AU  - Babatunde, O
AU  - Evans, AL
AU  - Jordan, JL
AU  - Paskins, Z
TI  -  Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review
J2  - Arch Osteoporos
SP  - 14
PY  - 2018
VL  - 13
SP  - 14
ER  - 
TY  - JOUR
LB  - 15.
AU  - Cramer, JA
AU  - Roy, A
AU  - Burrell, A
AU  - Fairchild, CJ
AU  - Fuldeore, MJ
AU  - Ollendorf, DA
AU  - Wong, PK
TI  -  Medication compliance and persistence: terminology and definitions
J2  - Value Health
SP  - 44
PY  - 2008
VL  - 11
SP  - 44
ER  - 
TY  - JOUR
LB  - 16.
AU  - Karlsson, L
AU  - Lundkvist, J
AU  - Psachoulia, E
AU  - Intorcia, M
AU  - Strom, O
TI  -  Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
J2  - Osteoporos Int
SP  - 2401
PY  - 2015
VL  - 26
SP  - 2401
ER  - 
TY  - JOUR
LB  - 17.
AU  - Cramer, JA
AU  - Gold, DT
AU  - Silverman, SL
AU  - Lewiecki, EM
TI  -  A systematic review of persistence and compliance with bisphosphonates for osteoporosis
J2  - Osteoporos Int
SP  - 1023
PY  - 2007
VL  - 18
SP  - 1023
ER  - 
TY  - JOUR
LB  - 18.
AU  - Recknor, C
AU  - Czerwinski, E
AU  - Bone, HG
AU  - Bonnick, SL
AU  - Binkley, N
AU  - Palacios, S
TI  -  Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial
J2  - Obstet Gynecol
SP  - 1291
PY  - 2013
VL  - 121
SP  - 1291
ER  - 
TY  - JOUR
LB  - 19.
AU  - Akarırmak, U
AU  - Koçyiğit, H
AU  - Eskiyurt, N
AU  - Esmaeilzadeh, S
AU  - Kuru, O
AU  - Yalçinkaya, EY
AU  - INSTRUCT Study Group
TI  -  Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: an observational study in Turkish patients with postmenopausal osteoporosis
J2  - Acta Orthop Traumatol Turc
SP  - 415
PY  - 2016
VL  - 50
SP  - 415
ER  - 
TY  - JOUR
LB  - 20.
AU  - Kishimoto, H
AU  - Maehara, M
TI  -  Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA
J2  - Arch Osteoporos
SP  - 231
PY  - 2015
VL  - 10
SP  - 231
ER  - 
TY  - JOUR
LB  - 21.
AU  - Durden, E
AU  - Pinto, L
AU  - Lopez-Gonzalez, L
AU  - Juneau, P
AU  - Barron, R
TI  -  Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States
J2  - Arch Osteoporos
SP  - 22
PY  - 2017
VL  - 12
SP  - 22
ER  - 
TY  - JOUR
LB  - 22.
AU  - Svedbom, A
AU  - Hernlund, E
AU  - Ivergård, M
AU  - Compston, J
AU  - Cooper, C
AU  - Stenmark, J
AU  - EU Review Panel of IOF
TI  -  The EU review panel of the IOF Osteoporosis in the European Union: a compendium of country-specific reports
J2  - Arch Osteoporos
SP  - 137
PY  - 2013
VL  - 8
SP  - 137
ER  - 
TY  - JOUR
LB  - 23.
AU  - Williamson, S
AU  - Landeiro, F
AU  - McConnell, T
AU  - Fulford-Smith, L
AU  - Javaid, MK
AU  - Judge, A
AU  - Leal, J
TI  -  Costs of fragility hip fractures globally: a systematic review and meta-regression analysis
J2  - Osteoporos Int
SP  - 2791
PY  - 2017
VL  - 28
SP  - 2791
ER  - 
TY  - JOUR
LB  - 24.
AU  - Borgström, F
AU  - Zethraeus, N
AU  - Johnell, O
AU  - Lidgren, L
AU  - Ponzer, S
AU  - Svensson, O
TI  -  Costs and quality of life associated with osteoporosis-related fractures in Sweden
J2  - Osteoporos Int
SP  - 637
PY  - 2006
VL  - 17
SP  - 637
ER  - 
TY  - JOUR
LB  - 25.
AU  - Tarride, JE
AU  - Burke, N
AU  - Leslie, WD
AU  - Morin, SN
AU  - Adachi, JD
AU  - Papaioannou, A
TI  -  Loss of health related quality of life following low-trauma fractures in the elderly
J2  - BMC Geriatr
SP  - 84
PY  - 2016
VL  - 16
SP  - 84
ER  - 
TY  - report
LB  - 26.
AU  - Royal College of Physicians
J2  - National Hip Fracture Database (NHFD): Annual Report 2017
ER  - 
TY  - JOUR
LB  - 27.
AU  - Ross, S
AU  - Samuels, E
AU  - Gairy, K
AU  - Iqbal, S
AU  - Badamgarav, E
AU  - Siris, E
TI  -  A meta-analysis of osteoporotic fracture risk with medication nonadherence
J2  - Value Health
SP  - 571
PY  - 2011
VL  - 14
SP  - 571
ER  - 
TY  - JOUR
LB  - 28.
AU  - Shalev, V
AU  - Sharman Moser, S
AU  - Goldshtein, I
AU  - Yu, J
AU  - Weil, C
AU  - Ish-Shalom, S
TI  -  Adherence With bisphosphonates and long-term risk of hip fractures: a nested case-control study using real-world data
J2  - Ann Pharmacother
SP  - 757
PY  - 2017
VL  - 51
SP  - 757
ER  - 
TY  - ELEC
LB  - 29.
AU  - Barker, KL
AU  - Toye, F
AU  - Minns Lowe, CJ
J2  - A Qualitative Systematic Review of Patients’ Experience of Osteoporosis Using Meta-ethnography
PY  - 2016
ER  - 
TY  - ELEC
LB  - 30.
AU  - Raybould, G
AU  - Babatunde, O
AU  - Evans, AL
AU  - Jordan, JL
AU  - Paskins, Z
J2  - Expressed Information Needs of Patients with Osteoporosis and/or Fragility Fractures: A Systematic Review
PY  - 2018
ER  - 
TY  - ELEC
LB  - 31.
AU  - Hiligsmann, M
AU  - Bours, SPG
AU  - Boonen, A
J2  - A Review of Patient Preferences for Osteoporosis Drug Treatment
PY  - 2015
ER  - 
TY  - JOUR
LB  - 32.
AU  - Hiligsmann, M
AU  - Dellaert, BG
AU  - Dirksen, CD
AU  - Watson, V
AU  - Bours, S
AU  - Goemaere, S
TI  -  Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment
J2  - Rheumatology
SP  - 1167
PY  - 2017
VL  - 56
SP  - 1167
ER  - 
TY  - ELEC
LB  - 33.
AU  - Salter, C
AU  - McDaid, L
AU  - Bhattacharya, D
AU  - Holland, R
AU  - Marshall, T
AU  - Howe, A
TI  -  Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study
J2  - PLOS ONE
ER  - 
TY  - JOUR
LB  - 34.
AU  - Shu, AD
AU  - Stedman, MR
AU  - Polinski, JM
AU  - Jan, SA
AU  - Patel, M
AU  - Truppo, C
TI  -  Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trial
J2  - Am J Manag Care
SP  - 417
PY  - 2009
VL  - 15
SP  - 417
ER  - 
TY  - JOUR
LB  - 35.
AU  - Nho, JH
AU  - Lee, YK
AU  - Ha, YC
AU  - Kim, CH
AU  - Suh, YS
AU  - Koo, KH
TI  -  Can alarming improve compliance with weekly bisphosphonate in patients with osteoporosis?
J2  - J Bone Metab
SP  - 51
PY  - 2016
VL  - 23
SP  - 51
ER  - 
TY  - JOUR
LB  - 36.
AU  - Seuffert, P
AU  - Sagebien, CA
AU  - McDonnell, M
AU  - O’Hara, DA
TI  -  Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice
J2  - Arch Osteoporos
SP  - 10
PY  - 2016
VL  - 11
SP  - 10
ER  - 
TY  - JOUR
LB  - 37.
AU  - Tuncel, T
AU  - Hasselberg, J
AU  - Peters, KM
TI  -  Compliance of osteoporosis patients with additional specific osteoporosis-training course
J2  - Orthopade
SP  - 256
PY  - 2017
VL  - 46
SP  - 256
ER  - 
TY  - JOUR
LB  - 38.
AU  - Nieuwlaat, R
AU  - Wilczynski, N
AU  - Navarro, T
AU  - Hobson, N
AU  - Jeffery, R
AU  - Keepanasseril, A
TI  -  Interventions for enhancing medication adherence
J2  - Cochrane Database Syst Rev
PY  - 2014
VL  - 2014
ER  - 
TY  - JOUR
LB  - 39.
AU  - Diez-Perez, A
AU  - Naylor, KE
AU  - Abrahamsen, B
AU  - Agnusdei, D
AU  - Brandi, ML
AU  - Cooper, C
AU  - Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society
TI  -  Recommendations for the screening of adherence to oral bisphosphonates
J2  - Osteoporos Int
SP  - 767
PY  - 2017
VL  - 28
SP  - 767
ER  - 
TY  - JOUR
LB  - 40.
AU  - Lee, S
AU  - Glendenning, P
AU  - Inderjeeth, CA
TI  -  Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009
J2  - Osteoporos Int
SP  - 741
PY  - 2011
VL  - 22
SP  - 741
ER  - 
TY  - JOUR
LB  - 41.
AU  - Tremblay, E
AU  - Perreault, S
AU  - Dorais, M
TI  -  Persistence with denosumab and zoledronic acid among older women: a population-based cohort study
J2  - Arch Osteoporos
SP  - 30
PY  - 2016
VL  - 11
SP  - 30
ER  - 
TY  - JOUR
LB  - 42.
AU  - Wong, SM
AU  - Pacey, S
AU  - Sahota, O
TI  -  Setting up a homecare service for zoledronic acid treatment of osteoporosis
J2  - Eur J Hosp Pharm
SP  - 364
PY  - 2016
VL  - 23
SP  - 364
ER  - 
TY  - JOUR
LB  - 43.
AU  - Marshall, L
AU  - Wong, SM
AU  - Sahota, O
TI  -  Innovative intravenous osteoporosis at home service
J2  - Age Ageing
SP  - i10
PY  - 2014
VL  - 43
SP  - i10
ER  - 
TY  - ELEC
LB  - 44.
ER  - 
TY  - JOUR
LB  - 45.
AU  - Davis, S
AU  - Martyn-St James, M
AU  - Sanderson, J
AU  - Stevens, J
AU  - Goka, E
AU  - Rawdin, A
TI  -  A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
J2  - Health Technol Assess
SP  - 1
PY  - 2016
VL  - 20
SP  - 1
ER  - 
TY  - JOUR
LB  - 46.
AU  - Jha, S
AU  - Wang, Z
AU  - Laucis, N
AU  - Bhattacharyya, T
TI  -  Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996–2012: an ecological analysis
J2  - J Bone Miner Res
SP  - 2179
PY  - 2015
VL  - 30
SP  - 2179
ER  - 
TY  - JOUR
LB  - 47.
AU  - Saini, SD
AU  - Schoenfeld, P
AU  - Kaulback, K
AU  - Dubinsky, MC
TI  -  Effect of medication dosing frequency on adherence in chronic diseases
J2  - Am J Manag Care
SP  - 22
PY  - 2009
VL  - 15
SP  - 22
ER  - 
TY  - JOUR
LB  - 48.
AU  - Hiligsmann, M
AU  - Bours, SPG
AU  - Boonen, A
TI  -  A review of patient preferences for osteoporosis drug treatment
J2  - Curr Rheumatol Rep
SP  - 61
PY  - 2015
VL  - 17
SP  - 61
ER  - 
TY  - JOUR
LB  - 49.
AU  - de Bekker-Grob, EW
AU  - Essink-Bot, ML
AU  - Meerding, WJ
AU  - Pols, HA
AU  - Koes, BW
AU  - Steyerberg, EW
TI  -  Patients’ preferences for osteoporosis drug treatment: a discrete choice experiment
J2  - Osteoporos Int
SP  - 1029
PY  - 2008
VL  - 19
SP  - 1029
ER  - 
TY  - JOUR
LB  - 50.
AU  - Alten, R
AU  - Krüger, K
AU  - Rellecke, J
AU  - Schiffner-Rohe, J
AU  - Behmer, O
AU  - Schiffhorst, G
AU  - Nolting, HD
TI  -  Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach
J2  - Patient Prefer Adherence
SP  - 2217
PY  - 2016
VL  - 10
SP  - 2217
ER  - 
TY  - JOUR
LB  - 51.
AU  - Feldstein, AC
AU  - Schneider, J
AU  - Smith, DH
AU  - Vollmer, WM
AU  - Rix, M
AU  - Glauber, H
TI  -  Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture
J2  - Osteoporos Int
SP  - 1527
PY  - 2008
VL  - 19
SP  - 1527
ER  - 
TY  - JOUR
LB  - 52.
AU  - Bliuc, D
AU  - Eisman, JA
AU  - Center, JR
TI  -  A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures
J2  - Osteoporos Int
SP  - 1309
PY  - 2006
VL  - 17
SP  - 1309
ER  - 
TY  - JOUR
LB  - 53.
AU  - Sekhon, M
AU  - Cartwright, M
AU  - Francis, JJ
TI  -  Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
J2  - BMC Health Serv Res
SP  - 88
PY  - 2017
VL  - 17
SP  - 88
ER  - 
TY  - JOUR
LB  - 54.
AU  - Dejean, D
AU  - Giacomini, M
AU  - Simeonov, D
AU  - Smith, A
TI  -  Finding qualitative research evidence for Health Technology Assessment
J2  - Qual Health Res
SP  - 1307
PY  - 2016
VL  - 26
SP  - 1307
ER  - 
TY  - JOUR
LB  - 55.
AU  - Carroll, C
AU  - Booth, A
AU  - Cooper, K
TI  -  A worked example of ‘best fit’ framework synthesis: a systematic review of views concerning the taking of some potential chemopreventive agents
J2  - BMC Med Res Methodol
SP  - 29
PY  - 2011
VL  - 11
SP  - 29
ER  - 
TY  - JOUR
LB  - 56.
AU  - Horne, R
AU  - Chapman, SCE
AU  - Parham, R
AU  - Freemantle, N
AU  - Forbes, A
AU  - Cooper, V
TI  -  Understanding patients’ adherence-related Beliefs about Medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework
J2  - PLOS ONE
SP  - e80633
PY  - 2013
VL  - 8
SP  - e80633
ER  - 
TY  - JOUR
LB  - 57.
AU  - Lewin, S
AU  - Booth, A
AU  - Glenton, C
AU  - Munthe-Kaas, H
AU  - Rashidian, A
AU  - Wainwright, M
TI  -  Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series
J2  - Implement Sci
SP  - 34
PY  - 2018
VL  - 13
SP  - 34
ER  - 
TY  - JOUR
LB  - 58.
AU  - Besser, SJ
AU  - Anderson, JE
AU  - Weinman, J
TI  -  How do osteoporosis patients perceive their illness and treatment? Implications for clinical practice
J2  - Arch Osteoporos
SP  - 115
PY  - 2012
VL  - 7
SP  - 115
ER  - 
TY  - JOUR
LB  - 59.
AU  - Sale, JEM
AU  - Beaton, D
AU  - Sujic, R
AU  - Bogoch, ER
TI  -  ‘If it was osteoporosis, I would have really hurt myself.’ Ambiguity about osteoporosis and osteoporosis care despite a screening programme to educate fragility fracture patients
J2  - J Eval Clin Pract
SP  - 590
PY  - 2010
VL  - 16
SP  - 590
ER  - 
TY  - JOUR
LB  - 60.
AU  - Sale, JEM
AU  - Hawker, G
AU  - Cameron, C
AU  - Bogoch, E
AU  - Jain, R
AU  - Beaton, D
TI  -  Perceived messages about bone health after a fracture are not consistent across healthcare providers
J2  - Rheumatol Int
SP  - 97
PY  - 2015
VL  - 35
SP  - 97
ER  - 
TY  - JOUR
LB  - 61.
AU  - Weston, JM
AU  - Norris, EV
AU  - Clark, EM
TI  -  The invisible disease: making sense of an osteoporosis diagnosis in older age
J2  - Qual Health Res
SP  - 1692
PY  - 2011
VL  - 21
SP  - 1692
ER  - 
TY  - JOUR
LB  - 62.
AU  - Hansen, CA
AU  - Abrahamsen, B
AU  - Konradsen, H
AU  - Pedersen, BD
TI  -  Women’s lived experiences of learning to live with osteoporosis: a longitudinal qualitative study
J2  - BMC Womens Health
SP  - 17
PY  - 2017
VL  - 17
SP  - 17
ER  - 
TY  - JOUR
LB  - 63.
AU  - Otmar, R
AU  - Reventlow, SD
AU  - Nicholson, GC
AU  - Kotowicz, MA
AU  - Pasco, JA
TI  -  General medical practitioners’ knowledge and beliefs about osteoporosis and its investigation and management
J2  - Arch Osteoporos
SP  - 107
PY  - 2012
VL  - 7
SP  - 107
ER  - 
TY  - JOUR
LB  - 64.
AU  - Jaglal, SB
AU  - Carroll, J
AU  - Hawker, G
AU  - McIsaac, WJ
AU  - Jaakkimainen, L
AU  - Cadarette, SM
TI  -  How are family physicians managing osteoporosis?: qualitative study of their experiences and educational needs
J2  - Can Fam Physician
SP  - 462
PY  - 2003
VL  - 49
SP  - 462
ER  - 
TY  - JOUR
LB  - 65.
AU  - Ailabouni, NJ
AU  - Nishtala, PS
AU  - Mangin, D
AU  - Tordoff, JM
TI  -  General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study
J2  - Int J Clin Pract
SP  - 261
PY  - 2016
VL  - 70
SP  - 261
ER  - 
TY  - JOUR
LB  - 66.
AU  - Sippli, K
AU  - Rieger, MA
AU  - Huettig, F
TI  -  GPs’ and dentists’ experiences and expectations of interprofessional collaboration: findings from a qualitative study in Germany
J2  - BMC Health Serv Res
SP  - 179
PY  - 2017
VL  - 17
SP  - 179
ER  - 
TY  - JOUR
LB  - 67.
AU  - Merle, B
AU  - Haesebaert, J
AU  - Bedouet, A
AU  - Barraud, L
AU  - Flori, M
AU  - Schott, AM
AU  - Dupraz, C
TI  -  Osteoporosis prevention: where are the barriers to improvement in French general practitioners? A qualitative study
J2  - PLOS ONE
SP  - e0219681
PY  - 2019
VL  - 14
SP  - e0219681
ER  - 
TY  - JOUR
LB  - 68.
AU  - Merle, B
AU  - Dupraz, C
AU  - Haesebaert, J
AU  - Barraud, L
AU  - Aussedat, M
AU  - Motteau, C
TI  -  Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study
J2  - Osteoporos Int
SP  - 177
PY  - 2019
VL  - 30
SP  - 177
ER  - 
TY  - JOUR
LB  - 69.
AU  - Drew, S
AU  - Judge, A
AU  - Cooper, C
AU  - Javaid, MK
AU  - Farmer, A
AU  - Gooberman-Hill, R
TI  -  Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery
J2  - Osteoporos Int
SP  - 1719
PY  - 2016
VL  - 27
SP  - 1719
ER  - 
TY  - JOUR
LB  - 70.
AU  - Alami, S
AU  - Hervouet, L
AU  - Poiraudeau, S
AU  - Briot, K
AU  - Roux, C
TI  -  Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of patients’ and practitioners’ views
J2  - PLOS ONE
SP  - e0158365
PY  - 2016
VL  - 11
SP  - e0158365
ER  - 
TY  - JOUR
LB  - 71.
AU  - Guzman-Clark, JRS
AU  - Fang, MA
AU  - Sehl, ME
AU  - Traylor, L
AU  - Hahn, TJ
TI  -  Barriers in the management of glucocorticoid-induced osteoporosis
J2  - Arthritis Care Res
SP  - 140
PY  - 2007
VL  - 57
SP  - 140
ER  - 
TY  - JOUR
LB  - 72.
AU  - Lau, E
AU  - Papaioannou, A
AU  - Dolovich, L
AU  - Adachi, J
AU  - Sawka, AM
AU  - Burns, S
TI  -  Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women
J2  - Can Fam Physician
SP  - 394
PY  - 2008
VL  - 54
SP  - 394
ER  - 
TY  - JOUR
LB  - 73.
AU  - Salter, C
AU  - McDaid, L
AU  - Bhattacharya, D
AU  - Holland, R
AU  - Marshall, T
AU  - Howe, A
TI  -  Abandoned acid? Understanding adherence to bisphosphonate medications for the prevention of osteoporosis among older women: a qualitative longitudinal study
J2  - PLOS ONE
SP  - e83552
PY  - 2014
VL  - 9
SP  - e83552
ER  - 
TY  - JOUR
LB  - 74.
AU  - Iversen, MD
AU  - Vora, RR
AU  - Servi, A
AU  - Solomon, DH
TI  -  Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers
J2  - J Geriatr Phys Ther
SP  - 72
PY  - 2011
VL  - 34
SP  - 72
ER  - 
TY  - JOUR
LB  - 75.
AU  - Mazor, KM
AU  - Velten, S
AU  - Andrade, SE
AU  - Yood, RA
TI  -  Older women’s views about prescription osteoporosis medication: a cross-sectional, qualitative study
J2  - Drugs Aging
SP  - 999
PY  - 2010
VL  - 27
SP  - 999
ER  - 
TY  - JOUR
LB  - 76.
AU  - Wozniak, LA
AU  - Johnson, JA
AU  - McAlister, FA
AU  - Beaupre, LA
AU  - Bellerose, D
AU  - Rowe, BH
AU  - Majumdar, SR
TI  -  Understanding fragility fracture patients’ decision-making process regarding bisphosphonate treatment
J2  - Osteoporos Int
SP  - 219
PY  - 2017
VL  - 28
SP  - 219
ER  - 
TY  - JOUR
LB  - 77.
AU  - Swart, KMA
AU  - Van Vilsteren, M
AU  - Van Hout, W
AU  - Draak, E
AU  - van der Zwaard, BC
AU  - van der Horst, HE
TI  -  Factors related to intentional non-initiation of bisphosphonate treatment in patients with a high fracture risk in primary care: a qualitative study
J2  - BMC Fam Pract
SP  - 141
PY  - 2018
VL  - 19
SP  - 141
ER  - 
TY  - JOUR
LB  - 78.
AU  - Scoville, EA
AU  - de Leon Lovaton, PP
AU  - Shah, ND
AU  - Pencille, LJ
AU  - Montori, VM
TI  -  Why do women reject bisphosphonates for osteoporosis? A videographic study
J2  - PLOS ONE
SP  - e18468
PY  - 2011
VL  - 6
SP  - e18468
ER  - 
TY  - JOUR
LB  - 79.
AU  - Sale, JEM
AU  - Gignac, MA
AU  - Hawker, G
AU  - Frankel, L
AU  - Beaton, D
AU  - Bogoch, E
AU  - Elliot-Gibson, V
TI  -  Decision to take osteoporosis medication in patients who have had a fracture and are ‘high’ risk for future fracture: a qualitative study
J2  - BMC Musculoskelet Disord
SP  - 92
PY  - 2011
VL  - 12
SP  - 92
ER  - 
TY  - JOUR
LB  - 80.
AU  - Sturrock, A
AU  - Preshaw, P
AU  - Hayes, C
AU  - Wilkes, S
TI  -  Attitudes and perceptions of GPs and community pharmacists towards their role in the prevention of bisphosphonate-related osteonecrosis of the jaw: a qualitative study in the North East of England
J2  - BMJ Open
SP  - e016047
PY  - 2017
VL  - 7
SP  - e016047
ER  - 
TY  - JOUR
LB  - 81.
AU  - Sturrock, A
AU  - Preshaw, PM
AU  - Hayes, C
AU  - Wilkes, S
TI  -  Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England
J2  - BMJ Open
SP  - e024376
PY  - 2019
VL  - 9
SP  - e024376
ER  - 
TY  - BOOK
LB  - 82.
AU  - Nunes, V
AU  - Neilson, J
AU  - O’flynn, N
J2  - Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence (CG76)
PY  - 2009
ER  - 
TY  - JOUR
LB  - 83.
AU  - Horne, R
AU  - Cooper, V
AU  - Wileman, V
AU  - Parham, R
AU  - Freemantle, N
AU  - Forbes, A
AU  - Cooper, V
TI  -  Supporting adherence to medicines for long-term conditions
J2  - Eur Psychol
SP  - 82
PY  - 2019
VL  - 24
SP  - 82
ER  - 
TY  - JOUR
LB  - 84.
AU  - Driesenaar, JA
AU  - De Smet, PA
AU  - van Hulten, R
AU  - Horne, R
AU  - Zwikker, H
AU  - van den Bemt, B
AU  - van Dulmen, S
TI  -  Beliefs about inhaled corticosteroids: comparison of community pharmacists, pharmacy technicians and patients with asthma
J2  - J Asthma
SP  - 1051
PY  - 2016
VL  - 53
SP  - 1051
ER  - 
TY  - JOUR
LB  - 85.
AU  - Checkland, K
AU  - Harrison, S
AU  - Marshall, M
TI  -  Is the metaphor of ‘barriers to change’ useful in understanding implementation? Evidence from general medical practice
J2  - J Heal Serv Res Policy
SP  - 95
PY  - 2007
VL  - 12
SP  - 95
ER  - 
TY  - JOUR
LB  - 86.
AU  - Neale, J
TI  -  Iterative categorization (IC): a systematic technique for analysing qualitative data
J2  - Addiction
SP  - 1096
PY  - 2016
VL  - 111
SP  - 1096
ER  - 
TY  - JOUR
LB  - 87.
AU  - Sekhon, M
AU  - Cartwright, M
AU  - Francis, JJ
TI  -  Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework
J2  - BMC Health Serv Res
SP  - 1
PY  - 2017
VL  - 17
SP  - 1
ER  - 
TY  - JOUR
LB  - 88.
AU  - Roh, YH
AU  - Noh, JH
AU  - Gong, HS
AU  - Baek, GH
TI  -  Comparative adherence to weekly oral and quarterly intravenous bisphosphonates among patients with limited heath literacy who sustained distal radius fractures
J2  - J Bone Miner Metab
SP  - 589
PY  - 2018
VL  - 36
SP  - 589
ER  - 
TY  - JOUR
LB  - 89.
AU  - Fraenkel, L
AU  - Gulanski, B
AU  - Wittink, D
TI  -  Patient treatment preferences for osteoporosis
J2  - Arthritis Care Res
SP  - 729
PY  - 2006
VL  - 55
SP  - 729
ER  - 
TY  - JOUR
LB  - 90.
AU  - Kendler, DL
AU  - Bessette, L
AU  - Hill, CD
AU  - Gold, DT
AU  - Horne, R
AU  - Varon, SF
TI  -  Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass
J2  - Osteoporos Int
SP  - 837
PY  - 2010
VL  - 21
SP  - 837
ER  - 
TY  - JOUR
LB  - 91.
AU  - Payer, J
AU  - Cierny, D
AU  - Killinger, Z
AU  - Sulková, I
AU  - Behuliak, M
AU  - Celec, P
TI  -  Preferences of patients with post-menopausal osteoporosis treated with bisphosphonates – the VIVA II study
J2  - J Int Med Res
SP  - 1225
PY  - 2009
VL  - 37
SP  - 1225
ER  - 
TY  - JOUR
LB  - 92.
AU  - Fjose, M
AU  - Eilertsen, G
AU  - Kirkevold, M
AU  - Grov, EK
TI  -  ‘Non-palliative care’ – a qualitative study of older cancer patients’ and their family members’ experiences with the health care system
J2  - BMC Health Serv Res
SP  - 745
PY  - 2018
VL  - 18
SP  - 745
ER  - 
TY  - JOUR
LB  - 93.
AU  - Selman, LE
AU  - Bristowe, K
AU  - Higginson, IJ
AU  - Murtagh, FEM
TI  -  The views and experiences of older people with conservatively managed renal failure: a qualitative study of communication, information and decision-making
J2  - BMC Nephrol
SP  - 1
PY  - 2019
VL  - 20
SP  - 1
ER  - 
TY  - ELEC
LB  - 94.
AU  - HSJ
J2  - Daily Insight: Long-term Plan, Short-sighted Move?
PY  - 2021
ER  - 
TY  - JOUR
LB  - 95.
AU  - Fallowfield, L
AU  - Stebbing, J
AU  - Braybrooke, J
AU  - Langridge, C
AU  - Jenkins, V
TI  -  The preferences and experiences of different bisphosphonate treatments in women with breast cancer
J2  - Psycho-Oncology
SP  - 755
PY  - 2011
VL  - 20
SP  - 755
ER  - 
TY  - JOUR
LB  - 96.
AU  - Horne, R
AU  - Chapman, SCE
AU  - Parham, R
AU  - Freemantle, N
AU  - Forbes, A
AU  - Cooper, V
TI  -  Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework
J2  - PLOS ONE
SP  - e80633
PY  - 2013
VL  - 8
SP  - e80633
ER  - 
TY  - JOUR
LB  - 97.
AU  - Qaseem, A
AU  - Forciea, MA
AU  - McLean, RM
AU  - Denberg, TD
AU  - Barry, MJ
AU  - Cooke, M
AU  - Clinical Guidelines Committee of the American College of Physicians
TI  -  Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians
J2  - Ann Intern Med
SP  - 818
PY  - 2017
VL  - 166
SP  - 818
ER  - 
TY  - JOUR
LB  - 98.
AU  - Fatoye, F
AU  - Smith, P
AU  - Gebrye, T
AU  - Yeowell, G
TI  -  Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
J2  - BMJ Open
SP  - e027049
PY  - 2019
VL  - 9
SP  - e027049
ER  - 
TY  - JOUR
LB  - 99.
AU  - Koller, G
AU  - Goetz, V
AU  - Vandermeer, B
AU  - Homik, J
AU  - McAlister, FA
AU  - KendlerYe, DC
TI  -  Persistence and adherence to parenteral osteoporosis therapies: a systematic review
J2  - Osteoporos Int
SP  - 2093
PY  - 2020
VL  - 31
SP  - 2093
ER  - 
TY  - JOUR
LB  - 100.
AU  - Vrijens, B
AU  - De Geest, S
AU  - Hughes, DA
AU  - Przemyslaw, K
AU  - Demonceau, J
AU  - Ruppar, T
TI  -  A new taxonomy for describing and defining adherence to medications
J2  - Br J Clin Pharmacol
SP  - 691
PY  - 2012
VL  - 73
SP  - 691
ER  - 
TY  - JOUR
LB  - 101.
AU  - De Geest, S
AU  - Zullig, LL
AU  - Dunbar-Jacob, J
AU  - Helmy, R
AU  - Hughes, DA
AU  - Wilson, IB
AU  - Vrijens, B
TI  -  ESPACOMP medication adherence reporting guideline (EMERGE)
J2  - Ann Intern Med
SP  - 30
PY  - 2018
VL  - 169
SP  - 30
ER  - 
TY  - JOUR
LB  - 102.
AU  - Hiligsmann, M
AU  - Cornelissen, D
AU  - Vrijens, B
AU  - Abrahamsen, B
AU  - Al- Daghri, N
AU  - Biver, E
TI  -  Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
J2  - Osteoporos Int
SP  - 2155
PY  - 2019
VL  - 30
SP  - 2155
ER  - 
TY  - BOOK
LB  - 103.
AU  - Chaimani, A
AU  - Caldwell, DM
AU  - Li, T
AU  - Higgins, JPT
AU  - Salanti, G
AU  - Higgins, JP
J2  - Cochrane Handbook for Systematic Reviews of Interventions
PY  - 2019
ER  - 
TY  - JOUR
LB  - 104.
AU  - McGuinness, LA
AU  - Higgins, JP
TI  -  Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments
J2  - Res Synth Methods
SP  - 55
PY  - 2021
VL  - 12
SP  - 55
ER  - 
TY  - JOUR
LB  - 105.
AU  - White, IR
TI  -  Network meta-analysis
J2  - Stata J
SP  - 951
PY  - 2015
VL  - 15
SP  - 951
ER  - 
TY  - JOUR
LB  - 106
AU  - Hutton, B
AU  - Salanti, G
AU  - Caldwell, DM
AU  - Chaimani, A
AU  - Schmid, CH
AU  - Cameron, C
TI  -  The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
J2  - Ann Intern Med
SP  - 777
PY  - 2015
VL  - 162
SP  - 777
ER  - 
TY  - BOOK
LB  - 107
AU  - Higgins, JT
AU  - Altman, D
AU  - Group CSM, Group CBM
TI  -  Chapter 8: Assessing risk of bias in included studies
J2  - Cochrane Handbook for Systematic Reviews of Interventions
PY  - 2011
ER  - 
TY  - JOUR
LB  - 108.
AU  - Sterne, JA
AU  - Hernán, MA
AU  - Reeves, BC
AU  - Savović, J
AU  - Berkman, ND
AU  - Viswanathan, M
TI  -  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
J2  - BMJ
SP  - 23
PY  - 2016
VL  - 355
SP  - 23
ER  - 
TY  - BOOK
LB  - 109.
AU  - Dias, S
AU  - Welton, NJ
AU  - Sutton, AJ
AU  - Ades, AE
J2  - NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. (Technical Support Document in Evidence Synthesis; No. TSD2)
PY  - 2012
ER  - 
TY  - JOUR
LB  - 110.
AU  - Dias, S
AU  - Sutton, AJ
AU  - Welton, NJ
AU  - Ades, AE
TI  -  Evidence synthesis for decision making 3: heterogeneity – subgroups, meta-regression, bias, and bias-adjustment
J2  - Med Decis Making
SP  - 618
PY  - 2013
VL  - 33
SP  - 618
ER  - 
TY  - JOUR
LB  - 111.
AU  - Salanti, G
AU  - Ades, AE
AU  - Ioannidis, JP
TI  -  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
J2  - J Clin Epidemiol
SP  - 163
PY  - 2011
VL  - 64
SP  - 163
ER  - 
TY  - BOOK
LB  - 112.
AU  - Dias, S
AU  - Ades, AE
AU  - Welton, NJ
AU  - Jansen, JP
AU  - Sutton, AJ
J2  - Chapter 4. Generalised Linear Models. Network Meta-Analysis for Decision-Making
PY  - 2018
ER  - 
TY  - JOUR
LB  - 113.
AU  - Dakin, HA
AU  - Welton, NJ
AU  - Ades, AE
AU  - Collins, S
AU  - Orme, M
AU  - Kelly, S
TI  -  Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open-angle glaucoma and ocular hypertension
J2  - Stat Med
SP  - 2511
PY  - 2011
VL  - 30
SP  - 2511
ER  - 
TY  - BOOK
LB  - 114.
AU  - Dias, S
AU  - Ades, AE
AU  - Welton, NJ
AU  - Jansen, JP
AU  - Sutton, AJ
J2  - Chapter 8. Meta-Regression for Relative Treatment Effects. Network Meta-Analysis for Decision-Making
PY  - 2018
ER  - 
TY  - BOOK
LB  - 115.
AU  - McKenzie, JE
AU  - Brennan, SE
AU  - Higgins, JP
AU  - Thomas, J
AU  - Chandler, J
AU  - Cumpston, M
AU  - Li, T
AU  - Page, MJ
AU  - Welch, VA
TI  -  Chapter 12: Synthesizing and presenting findings using other methods
J2  - Cochrane Handbook for Systematic Reviews of Interventions
PY  - 2019
ER  - 
TY  - JOUR
LB  - 116.
AU  - Thomson, HJ
AU  - Thomas, S
TI  -  The effect direction plot: visual display of non-standardised effects across multiple outcome domains
J2  - Res Synth Methods
SP  - 95
PY  - 2013
VL  - 4
SP  - 95
ER  - 
TY  - JOUR
LB  - 117.
AU  - Dias, S
AU  - Welton, NJ
AU  - Caldwell, DM
AU  - Ades, AE
TI  -  Checking consistency in mixed treatment comparison meta-analysis
J2  - Stat Med
SP  - 932
PY  - 2010
VL  - 29
SP  - 932
ER  - 
TY  - BOOK
LB  - 118.
AU  - Dias, S
AU  - Ades, AE
AU  - Welton, NJ
AU  - Jansen, JP
AU  - Sutton, AJ
J2  - Chapter 7. Checking for Inconsistency. Network Meta-Analysis for Decision-Making
PY  - 2018
ER  - 
TY  - JOUR
LB  - 119.
AU  - van Valkenhoef, G
AU  - Dias, S
AU  - Ades, AE
AU  - Welton, NJ
TI  -  Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis
J2  - Res Synth Methods
SP  - 80
PY  - 2016
VL  - 7
SP  - 80
ER  - 
TY  - JOUR
LB  - 120.
AU  - Nikolakopoulou, A
AU  - Higgins, JP
AU  - Papakonstantinou, T
AU  - Chaimani, A
AU  - Del Giovane, C
AU  - Egger, M
AU  - Salanti, G
TI  -  CINeMA: an approach for assessing confidence in the results of a network meta-analysis
J2  - PLOS Med
SP  - e1003082
PY  - 2020
VL  - 17
SP  - e1003082
ER  - 
TY  - JOUR
LB  - 121.
AU  - Papakonstantinou, T
AU  - Nikolakopoulou, A
AU  - Higgins, JP
AU  - Egger, M
AU  - Salanti, G
TI  -  CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis
J2  - Campbell System Rev
SP  - e1080
PY  - 2020
VL  - 16
SP  - e1080
ER  - 
TY  - JOUR
LB  - 122.
AU  - Tan, W
AU  - Sun, J
AU  - Zhou, L
AU  - Li, Y
AU  - Wu, X
TI  -  Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with postmenopausal osteoporosis
J2  - J Clin Pharm Ther
SP  - 519
PY  - 2016
VL  - 41
SP  - 519
ER  - 
TY  - JOUR
LB  - 123.
AU  - Hu, W
AU  - Wang, H
AU  - Shi, X
AU  - Song, Y
AU  - Zhang, G
AU  - Xing, S
TI  -  Effect of preoperative zoledronic acid administration on pain intensity after percutaneous vertebroplasty for osteoporotic vertebral compression fractures
J2  - Pain Res Manag
SP  - 1
PY  - 2020
VL  - 2020
SP  - 1
ER  - 
TY  - JOUR
LB  - 124.
AU  - Li, H
AU  - Li, C
AU  - Yi, X
AU  - Liu, H
AU  - Wang, Y
TI  -  Effects of sodium alendronate on osteoporosis and apoptosisrelated factors Cyt C, Apaf-1 and caspase-9
J2  - Biomed Res
SP  - 121
PY  - 2018
VL  - 29
SP  - 121
ER  - 
TY  - JOUR
LB  - 125.
AU  - Li, Y
AU  - Zhao, WB
AU  - Wang, DL
AU  - He, Q
AU  - Li, Q
AU  - Pei, FX
AU  - Liu, L
TI  -  Treatment of osteoporotic intertrochanteric fractures by zoledronic acid injection combined with proximal femoral nail antirotation
J2  - Chin J Traumatol
SP  - 259
PY  - 2016
VL  - 19
SP  - 259
ER  - 
TY  - JOUR
LB  - 126.
AU  - Liang, BC
AU  - Shi, ZY
AU  - Wang, B
AU  - Wu, P
AU  - Kong, LC
AU  - Yao, JL
TI  -  Intravenous zoledronic acid 5 mg on bone turnover markers and bone mineral density in East China subjects with newly diagnosed osteoporosis: a 24-month Clinical Study
J2  - Orthop Surg
SP  - 103
PY  - 2017
VL  - 9
SP  - 103
ER  - 
TY  - JOUR
LB  - 127.
AU  - Liu, Z
AU  - Li, CW
AU  - Mao, YF
AU  - Liu, K
AU  - Liang, BC
AU  - Wu, LG
AU  - Shi, XL
TI  -  Study on zoledronic acid reducing acute bone loss and fracture rates in elderly postoperative patients with intertrochanteric fractures
J2  - Orthop Surg
SP  - 380
PY  - 2019
VL  - 11
SP  - 380
ER  - 
TY  - JOUR
LB  - 128.
AU  - Shi, ZY
AU  - Zhang, XG
AU  - Li, CW
AU  - Liu, K
AU  - Liang, BC
AU  - Shi, XL
TI  -  Effect of traditional Chinese medicine product, QiangGuYin, on bone mineral density and bone turnover in Chinese postmenopausal osteoporosis
J2  - Evid Based Complementary Altern Med
SP  - 1
PY  - 2017
VL  - 2017
SP  - 1
ER  - 
TY  - JOUR
LB  - 129.
AU  - Zhang, J
AU  - Zhang, T
AU  - Xu, X
AU  - Cai, Q
AU  - Zhao, D
TI  -  Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women
J2  - Osteoporos Int
SP  - 1475
PY  - 2019
VL  - 30
SP  - 1475
ER  - 
TY  - JOUR
LB  - 130.
AU  - Zhang, ZL
AU  - Liao, EY
AU  - Xia, WB
AU  - Lin, H
AU  - Cheng, Q
AU  - Wang, L
TI  -  Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension
J2  - Osteoporos Int
SP  - 2719
PY  - 2015
VL  - 26
SP  - 2719
ER  - 
TY  - JOUR
LB  - 131.
AU  - Zhou, J
AU  - Liu, B
AU  - Qin, MZ
AU  - Liu, JP
TI  -  Fall prevention and anti-osteoporosis in osteopenia patients of 80 years of age and older: a randomized controlled study
J2  - Orthop Surg
SP  - 890
PY  - 2020
VL  - 12
SP  - 890
ER  - 
TY  - JOUR
LB  - 132.
AU  - Paggiosi, MA
AU  - Peel, N
AU  - McCloskey, E
AU  - Walsh, JS
AU  - Eastell, R
TI  -  Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study
J2  - Osteoporos Int
SP  - 2729
PY  - 2014
VL  - 25
SP  - 2729
ER  - 
TY  - JOUR
LB  - 133.
AU  - Eastell, R
AU  - Nagase, S
AU  - Ohyama, M
AU  - Small, M
AU  - Sawyer, J
AU  - Boonen, S
TI  -  Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: the OCEAN study
J2  - J Bone Miner Res
SP  - 1303
PY  - 2011
VL  - 26
SP  - 1303
ER  - 
TY  - JOUR
LB  - 134.
AU  - Cesareo, R
AU  - Di Stasio, E
AU  - Vescini, F
AU  - Campagna, G
AU  - Cianni, R
AU  - Pasqualini, V
TI  -  Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
J2  - Osteoporos Int
SP  - 1295
PY  - 2015
VL  - 26
SP  - 1295
ER  - 
TY  - JOUR
LB  - 135.
AU  - Livi, L
AU  - Scotti, V
AU  - Desideri, I
AU  - Saieva, C
AU  - Cecchini, S
AU  - Francolini, G
TI  -  Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial
J2  - Eur J Cancer
SP  - 100
PY  - 2019
VL  - 108
SP  - 100
ER  - 
TY  - JOUR
LB  - 136.
AU  - Popp, AW
AU  - Buffat, H
AU  - Cavelti, A
AU  - Windolf, M
AU  - Perrelet, R
AU  - Senn, C
AU  - Lippuner, K
TI  -  Cortical bone loss at the tibia in postmenopausal women with osteoporosis is associated with incident non-vertebral fractures: results of a randomized controlled ancillary study of HORIZON
J2  - Maturitas
SP  - 287
PY  - 2014
VL  - 77
SP  - 287
ER  - 
TY  - JOUR
LB  - 137.
AU  - Cosman, F
AU  - Gilchrist, N
AU  - McClung, M
AU  - Foldes, J
AU  - de Villiers, T
AU  - Santora, A
TI  -  A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates
J2  - Osteoporos Int
SP  - 377
PY  - 2016
VL  - 27
SP  - 377
ER  - 
TY  - JOUR
LB  - 138.
AU  - Greenspan, SL
AU  - Perera, S
AU  - Ferchak, MA
AU  - Nace, DA
AU  - Resnick, NM
TI  -  Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial
J2  - JAMA Intern Med
SP  - 913
PY  - 2015
VL  - 175
SP  - 913
ER  - 
TY  - JOUR
LB  - 139.
AU  - Greenspan, SL
AU  - Vujevich, KT
AU  - Brufsky, A
AU  - Lembersky, BC
AU  - van Londen, GJ
AU  - Jankowitz, RC
TI  -  Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
J2  - Osteoporos Int
SP  - 1857
PY  - 2015
VL  - 26
SP  - 1857
ER  - 
TY  - JOUR
LB  - 140.
AU  - Grey, A
AU  - Bolland, M
AU  - Wong, S
AU  - Horne, A
AU  - Gamble, G
AU  - Reid, IR
TI  -  Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial
J2  - J Clin Endocrinol Metab
SP  - 286
PY  - 2012
VL  - 97
SP  - 286
ER  - 
TY  - JOUR
LB  - 141.
AU  - Cheung, AS
AU  - Hoermann, R
AU  - Ghasem-Zadeh, A
AU  - Tinson, AJ
AU  - Ly, V
AU  - Milevski, SV
TI  -  Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomized controlled trial
J2  - J Bone Miner Res
SP  - 1871
PY  - 2020
VL  - 35
SP  - 1871
ER  - 
TY  - JOUR
LB  - 142.
AU  - Reid, IR
AU  - Horne, AM
AU  - Mihov, B
AU  - Stewart, A
AU  - Garratt, E
AU  - Wong, S
TI  -  Fracture prevention with zoledronate in older women with osteopenia
J2  - N Engl J Med
SP  - 2407
PY  - 2018
VL  - 379
SP  - 2407
ER  - 
TY  - JOUR
LB  - 143.
AU  - Nakamura, T
AU  - Fukunaga, M
AU  - Nakano, T
AU  - Kishimoto, H
AU  - Ito, M
AU  - Hagino, H
TI  -  Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)
J2  - Osteoporos Int
SP  - 389
PY  - 2017
VL  - 28
SP  - 389
ER  - 
TY  - JOUR
LB  - 144.
AU  - Shin, K
AU  - Park, SH
AU  - Park, W
AU  - Baek, HJ
AU  - Lee, YJ
AU  - Kang, SW
TI  -  Monthly oral ibandronate reduces bone loss in Korean women with rheumatoid arthritis and osteopenia receiving long-term glucocorticoids: a 48-week double-blinded randomized placebo-controlled investigator-initiated trial
J2  - Clin Ther
SP  - 268
PY  - 2017
VL  - 39
SP  - 268
ER  - 
TY  - JOUR
LB  - 145.
AU  - McClung, MR
AU  - Grauer, A
AU  - Boonen, S
AU  - Bolognese, MA
AU  - Brown, JP
AU  - Diez-Perez, A
TI  -  Romosozumab in postmenopausal women with low bone mineral density
J2  - N Engl J Med
SP  - 412
PY  - 2014
VL  - 370
SP  - 412
ER  - 
TY  - JOUR
LB  - 146.
AU  - Sestak, I
AU  - Singh, S
AU  - Cuzick, J
AU  - Blake, GM
AU  - Patel, R
AU  - Gossiel, F
TI  -  Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial
J2  - Lancet Oncol
SP  - 1460
PY  - 2014
VL  - 15
SP  - 1460
ER  - 
TY  - JOUR
LB  - 147.
AU  - Black, DM
AU  - Reid, IR
AU  - Cauley, JA
AU  - Cosman, F
AU  - Leung, PC
AU  - Lakatos, P
TI  -  The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT)
J2  - J Bone Miner Res
SP  - 934
PY  - 2015
VL  - 30
SP  - 934
ER  - 
TY  - JOUR
LB  - 148.
AU  - Grey, A
AU  - Bolland, M
AU  - Mihov, B
AU  - Wong, S
AU  - Horne, A
AU  - Gamble, G
AU  - Reid, IR
TI  -  Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial
J2  - J Bone Miner Res
SP  - 166
PY  - 2014
VL  - 29
SP  - 166
ER  - 
TY  - JOUR
LB  - 149.
AU  - Grey, A
AU  - Bolland, MJ
AU  - Horne, A
AU  - Mihov, B
AU  - Gamble, G
AU  - Reid, IR
TI  -  Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial
J2  - CMAJ
SP  - E1130
PY  - 2017
VL  - 189
SP  - E1130
ER  - 
TY  - JOUR
LB  - 150.
AU  - Eastell, R
AU  - Nagase, S
AU  - Small, M
AU  - Boonen, S
AU  - Spector, T
AU  - Ohyama, M
TI  -  Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study
J2  - J Bone Miner Res
SP  - 458
PY  - 2014
VL  - 29
SP  - 458
ER  - 
TY  - JOUR
LB  - 151.
AU  - Kanis, JA
AU  - Harvey, NC
AU  - McCloskey, E
AU  - Bruyère, O
AU  - Veronese, N
AU  - Lorentzon, M
TI  -  Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
J2  - Osteoporos Int
SP  - 1
PY  - 2020
VL  - 31
SP  - 1
ER  - 
TY  - JOUR
LB  - 152.
AU  - Kendler, DL
AU  - Marin, F
AU  - Zerbini, CA
AU  - Russo, LA
AU  - Greenspan, SL
AU  - Zikan, V
TI  -  Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
J2  - Lancet
SP  - 230
PY  - 2018
VL  - 391
SP  - 230
ER  - 
TY  - JOUR
LB  - 153.
AU  - Saag, KG
AU  - Petersen, J
AU  - Brandi, ML
AU  - Karaplis, AC
AU  - Lorentzon, M
AU  - Thomas, T
TI  -  Romosozumab or alendronate for fracture prevention in women with osteoporosis
J2  - N Engl J Med
SP  - 1417
PY  - 2017
VL  - 377
SP  - 1417
ER  - 
TY  - JOUR
LB  - 154.
AU  - Banefelt, J
AU  - Åkesson, KE
AU  - Spångeus, A
AU  - Ljunggren, O
AU  - Karlsson, L
AU  - Ström, O
TI  -  Risk of imminent fracture following a previous fracture in a Swedish database study
J2  - Osteoporos Int
SP  - 601
PY  - 2019
VL  - 30
SP  - 601
ER  - 
TY  - JOUR
LB  - 155.
AU  - Balasubramanian, A
AU  - Zhang, J
AU  - Chen, L
AU  - Wenkert, D
AU  - Daigle, SG
AU  - Grauer, A
AU  - Curtis, JR
TI  -  Risk of subsequent fracture after prior fracture among older women
J2  - Osteoporos Int
SP  - 79
PY  - 2019
VL  - 30
SP  - 79
ER  - 
TY  - JOUR
LB  - 156.
AU  - Noirmain, C
AU  - Gil-Wey, B
AU  - Pichon, I
AU  - Brindel, P
AU  - Haller, G
TI  -  Factors associated with patient willingness to participate in anaesthesia clinical trials: a vignette-based cross-sectional study
J2  - BMC Med Res Methodol
SP  - 1
PY  - 2020
VL  - 20
SP  - 1
ER  - 
TY  - JOUR
LB  - 157.
AU  - Avis, NE
AU  - Smith, KW
AU  - Link, CL
AU  - Hortobagyi, GN
AU  - Rivera, E
TI  -  Factors associated with participation in breast cancer treatment clinical trials
J2  - J Clin Oncol
SP  - 1860
PY  - 2006
VL  - 24
SP  - 1860
ER  - 
TY  - JOUR
LB  - 158.
AU  - Curtis, JR
AU  - Yun, H
AU  - Matthews, R
AU  - Saag, KG
AU  - Delzell, E
TI  -  Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population
J2  - Arthritis Care Res
SP  - 1054
PY  - 2012
VL  - 64
SP  - 1054
ER  - 
TY  - JOUR
LB  - 159.
AU  - Selak, V
AU  - Elley, CR
AU  - Bullen, C
AU  - Crengle, S
AU  - Wadham, A
AU  - Rafter, N
TI  -  Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
J2  - BMJ
SP  - g3318
PY  - 2014
VL  - 348
SP  - g3318
ER  - 
TY  - JOUR
LB  - 160.
AU  - Watts, NB
AU  - Chines, A
AU  - Olszynski, WP
AU  - McKeever, CD
AU  - McClung, MR
AU  - Zhou, X
AU  - Grauer, A
TI  -  Fracture risk remains reduced one year after discontinuation of risedronate
J2  - Osteoporos Int
SP  - 365
PY  - 2008
VL  - 19
SP  - 365
ER  - 
TY  - ELEC
LB  - 161.
AU  - National Osteoporosis Guideline Group
J2  - NOGG 2017: Clinical Guideline for the Prevention and Treatment of Osteoporosis
PY  - 2017
ER  - 
TY  - JOUR
LB  - 162.
AU  - Morley, J
AU  - Moayyeri, A
AU  - Ali, L
AU  - Taylor, A
AU  - Feudjo-Tepie, M
AU  - Hamilton, L
AU  - Bayly, J
TI  -  Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink
J2  - Osteoporos Int
SP  - 533
PY  - 2020
VL  - 31
SP  - 533
ER  - 
TY  - JOUR
LB  - 163.
AU  - Guyot, P
AU  - Ades, AE
AU  - Ouwens, MJNM
AU  - Welton, NJ
TI  -  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
J2  - BMC Med Res Methodol
SP  - 9
PY  - 2012
VL  - 12
SP  - 9
ER  - 
TY  - JOUR
LB  - 164.
AU  - Spångeus, A
AU  - Johansson, S
AU  - Woisetschläger, M
TI  -  Adherence to and persistence with zoledronic acid treatment for osteoporosis – reasons for early discontinuation
J2  - Arch Osteoporos
SP  - 58
PY  - 2020
VL  - 15
SP  - 58
ER  - 
TY  - ELEC
LB  - 165.
AU  - NHS Business Services Authority
J2  - Prescription Cost Analysis – England
PY  - 2021
ER  - 
TY  - JOUR
LB  - 166.
AU  - Schwartz, AV
AU  - Bauer, DC
AU  - Cummings, SR
AU  - Cauley, JA
AU  - Ensrud, KE
AU  - Palermo, L
AU  - FLEX Research Group
TI  -  Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial
J2  - J Bone Miner Res
SP  - 976
PY  - 2010
VL  - 25
SP  - 976
ER  - 
TY  - JOUR
LB  - 167.
AU  - Black, DM
AU  - Reid, IR
AU  - Boonen, S
AU  - Bucci-Rechtweg, C
AU  - Cauley, JA
AU  - Cosman, F
TI  -  The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
J2  - J Bone Miner Res
SP  - 243
PY  - 2012
VL  - 27
SP  - 243
ER  - 
TY  - JOUR
LB  - 168.
AU  - Eastell, R
AU  - Hannon, RA
AU  - Wenderoth, D
AU  - Rodriguez-Moreno, J
AU  - Sawicki, A
TI  -  Effect of stopping risedronate after long-term treatment on bone turnover
J2  - J Clin Endocrinol Metab
SP  - 3367
PY  - 2011
VL  - 96
SP  - 3367
ER  - 
TY  - JOUR
LB  - 169.
AU  - Ravn, P
AU  - Christensen, JO
AU  - Baumann, M
AU  - Clemmesen, B
TI  -  Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: prediction of bone mass changes during treatment
J2  - Bone
SP  - 559
PY  - 1998
VL  - 22
SP  - 559
ER  - 
TY  - JOUR
LB  - 170.
AU  - Davis, S
AU  - Simpson, E
AU  - Hamilton, J
AU  - Martyn-St James, M
AU  - Rawdin, A
AU  - Wong, R
TI  -  Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
J2  - Health Technol
SP  - 1
PY  - 2020
VL  - 24
SP  - 1
ER  - 
TY  - JOUR
LB  - 171.
AU  - Reginster, JY
AU  - Adami, S
AU  - Lakatos, P
AU  - Greenwald, M
AU  - Stepan, JJ
AU  - Silverman, SL
TI  -  Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
J2  - Ann Rheum Dis
SP  - 654
PY  - 2006
VL  - 65
SP  - 654
ER  - 
TY  - JOUR
LB  - 172.
AU  - Delmas, PD
AU  - Adami, S
AU  - Strugala, C
AU  - Stakkestad, JA
AU  - Reginster, JY
AU  - Felsenberg, D
TI  -  Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study
J2  - Arthritis Rheum
SP  - 1838
PY  - 2006
VL  - 54
SP  - 1838
ER  - 
TY  - JOUR
LB  - 173.
AU  - Eisman, JA
AU  - Civitelli, R
AU  - Adami, S
AU  - Czerwinski, E
AU  - Recknor, C
AU  - Prince, R
TI  -  Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
J2  - J Rheumatol
SP  - 488
PY  - 2008
VL  - 35
SP  - 488
ER  - 
TY  - JOUR
LB  - 174.
AU  - Reid, IR
AU  - Gamble, GD
AU  - Mesenbrink, P
AU  - Lakatos, P
AU  - Black, DM
TI  -  Characterization of and risk factors for the acute-phase response after zoledronic acid
J2  - J Clin Endocrinol Metab
SP  - 4380
PY  - 2010
VL  - 95
SP  - 4380
ER  - 
TY  - JOUR
LB  - 175.
AU  - van Hoek, AJ
AU  - Underwood, A
AU  - Jit, M
AU  - Miller, E
AU  - Edmunds, WJ
TI  -  The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study
J2  - PLOS ONE
SP  - e17030
PY  - 2011
VL  - 6
SP  - e17030
ER  - 
TY  - BOOK
LB  - 176.
AU  - Curtis, L
AU  - Burns, A
J2  - Unit Costs of Health and Social Care 2020
PY  - 2020
ER  - 
TY  - JOUR
LB  - 177.
AU  - Gutiérrez, L
AU  - Roskell, N
AU  - Castellsague, J
AU  - Beard, S
AU  - Rycroft, C
AU  - Abeysinghe, S
TI  -  Study of the incremental cost and clinical burden of hip fractures in postmenopausal women in the United Kingdom
J2  - J Med Econ
SP  - 99
PY  - 2011
VL  - 14
SP  - 99
ER  - 
TY  - JOUR
LB  - 178.
AU  - Gutiérrez, L
AU  - Roskell, N
AU  - Castellsague, J
AU  - Beard, S
AU  - Rycroft, C
AU  - Abeysinghe, S
TI  -  Clinical burden and incremental cost of fractures in postmenopausal women in the United Kingdom
J2  - Bone
SP  - 324
PY  - 2012
VL  - 51
SP  - 324
ER  - 
TY  - JOUR
LB  - 179.
AU  - Ström, O
AU  - Borgström, F
AU  - Zethraeus, N
AU  - Johnell, O
AU  - Lidgren, L
AU  - Ponzer, S
TI  -  Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden
J2  - Acta Orthop
SP  - 269
PY  - 2008
VL  - 79
SP  - 269
ER  - 
TY  - JOUR
LB  - 180.
AU  - Svedbom, A
AU  - Borgstöm, F
AU  - Hernlund, E
AU  - Ström, O
AU  - Alekna, V
AU  - Bianchi, ML
TI  -  Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS
J2  - Osteoporos Int
SP  - 557
PY  - 2018
VL  - 29
SP  - 557
ER  - 
TY  - JOUR
LB  - 181.
AU  - Abimanyi-Ochom, J
AU  - Watts, JJ
AU  - Borgström, F
AU  - Nicholson, GC
AU  - Shore-Lorenti, C
AU  - Stuart, AL
TI  -  Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS)
J2  - Osteoporos Int
SP  - 1781
PY  - 2015
VL  - 26
SP  - 1781
ER  - 
TY  - GEN
LB  - 182.
AU  - National Institute for Health and Care Excellence (NICE)
J2  - Guide to the Methods of Technology Appraisal 2013
PY  - 2013
ER  - 
TY  - JOUR
LB  - 183.
AU  - Strong, M
AU  - Oakley, JE
AU  - Brennan, A
TI  -  Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach
J2  - Med Decis Making
SP  - 311
PY  - 2014
VL  - 34
SP  - 311
ER  - 
TY  - JOUR
LB  - 184.
AU  - Doble, B
AU  - Payne, R
AU  - Harshfield, A
AU  - Wilson, ECF
TI  -  Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (< 60 days) or long (≥ 60 days) prescription lengths in primary care for common, chronic conditions in the UK
J2  - BMJ Open
SP  - e019382
PY  - 2017
VL  - 7
SP  - e019382
ER  - 
TY  - JOUR
LB  - 185.
AU  - de Wit, MP
AU  - Berlo, SE
AU  - Aanerud, GJ
AU  - Aletaha, D
AU  - Bijlsma, JW
AU  - Croucher, L
TI  -  European league against rheumatism recommendations for the inclusion of patient representatives in scientific projects
J2  - Ann Rheum Dis
SP  - 722
PY  - 2011
VL  - 70
SP  - 722
ER  - 
TY  - JOUR
LB  - 186.
AU  - Crowe, S
AU  - Fenton, M
AU  - Hall, M
AU  - Cowan, K
AU  - Chalmers, I
TI  -  Patients’, clinicians’ and the research communities’ priorities for treatment research: there is an important mismatch
J2  - Res Involv Engagem
SP  - 14
PY  - 2015
VL  - 1
SP  - 14
ER  - 
TY  - JOUR
LB  - 187.
AU  - Hernlund, E
AU  - Svedbom, A
AU  - Ivergård, M
AU  - Compston, J
AU  - Cooper, C
AU  - Stenmark, J
TI  -  Osteoporosis in the European Union: medical management, epidemiology and economic burden
J2  - Arch Osteoporos
SP  - 136
PY  - 2017
VL  - 8
SP  - 136
ER  - 
TY  - JOUR
LB  - 188.
AU  - Cooper, C
TI  -  The crippling consequences of fractures and their impact on quality of life
J2  - Am J Med
SP  - S12
PY  - 1997
VL  - 103
SP  - S12
ER  - 
TY  - ELEC
LB  - 189.
AU  - Cochrane methods Priority Setting
J2  - Top Tips for Research Priority Setting
PY  - 2015
ER  - 
TY  - JOUR
LB  - 190.
AU  - Mahmood, W
AU  - Jinks, C
AU  - Jayakumar, P
AU  - Gwilym, S
AU  - Paskins, Z
TI  -  115 public priority setting for research in osteoporosis
J2  - Rheumatology
SP  - 109
PY  - 2016
VL  - 55
SP  - 109
ER  - 
TY  - JOUR
LB  - 191.
AU  - Jinks, C
AU  - Carter, P
AU  - Rhodes, C
AU  - Taylor, R
AU  - Beech, R
AU  - Dziedzic, K
TI  -  Patient and public involvement in primary care research-an example of ensuring its sustainability
J2  - Res Involv Engagem
SP  - 1
PY  - 2016
VL  - 2
SP  - 1
ER  - 
TY  - JOUR
LB  - 192.
AU  - Chalmers, I
AU  - Bracken, MB
AU  - Djulbegovic, B
AU  - Garattini, S
AU  - Grant, J
AU  - Gülmezoglu, AM
TI  -  How to increase value and reduce waste when research priorities are set
J2  - Lancet
SP  - 156
PY  - 2014
VL  - 383
SP  - 156
ER  - 
TY  - JOUR
LB  - 193.
AU  - Partridge, N
AU  - Scadding, J
TI  -  The James Lind Alliance: patients and clinicians should jointly identify their priorities for clinical trials
J2  - Lancet
SP  - 1923
PY  - 2014
VL  - 364
SP  - 1923
ER  - 
TY  - BOOK
LB  - 194.
AU  - Staley, K
AU  - Hanley, B
J2  - Scoping Research Priority Setting (and the Presence of PPI in Priority Setting) with UK Clinical Research Organisations and Funders
PY  - 2018
ER  - 
TY  - JOUR
LB  - 195.
AU  - Paskins, Z
AU  - Jinks, C
AU  - Mahmood, W
AU  - Jayakumar, P
AU  - Sangan, CB
AU  - Belcher, J
AU  - Gwilym, S
TI  -  Public priorities for osteoporosis and fracture research: results from a general population survey
J2  - Arch Osteoporos
SP  - 1
PY  - 2017
VL  - 12
SP  - 1
ER  - 
TY  - ELEC
LB  - 196.
AU  - Katherine Cowan, Senior Advisor to JLA, Sandy Oliver, Professor of Public Policy at Social Science Research Unit and EPPI-Centre, Institute of Education, University of London; James Lind Alliance (JLA) Guidebook, Chapter 1. Katherine oversaw versions 1 – 5. The JLA team at the School of Healthcare Enterprise and Innovation
J2  - University of Southampton, and Katherine Cowan, with input from the JLA Advisers, have updated versions 6 onwards
ER  - 
TY  - JOUR
LB  - 197.
AU  - Richardson, WS
AU  - Wilson, MC
AU  - Nishikawa, J
AU  - Hayward, RS
TI  -  The well-built clinical question: a key to evidence-based decisions
J2  - ACP J Club
SP  - A12
PY  - 1995
VL  - 123
SP  - A12
ER  - 
TY  - ELEC
LB  - 198.
AU  - Katherine Cowan, Senior Advisor to JLA, Sandy Oliver, Professor of Public Policy at Social Science Research Unit and EPPI-Centre, Institute of Education, University of London; James Lind Alliance (JLA) Guidebook, Chapter 7 Report on JLA PSP online priority setting workshop – Caroline Whiting, School of Healthcare Enterprise and Innovation, University of Southampton
ER  - 
TY  - ELEC
LB  - 199.
AU  - National Institute for Health and Care Excellence (NICE)
J2  - Alendronate, Etidronate, Risedronate, Raloxifene and Strontium Ranelate for the Primary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women
PY  - 2008
ER  - 
TY  - ELEC
LB  - 200.
AU  - National Institute for Health and Care Excellence (NICE)
J2  - Alendronate, Etidronate, Risedronate, Raloxifene, Strontium Ranelate and Teriparatide for the Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women
PY  - 2008
ER  - 
TY  - JOUR
LB  - 201.
AU  - Grossman, JM
AU  - Gordon, R
AU  - Ranganath, VK
AU  - Deal, C
AU  - Caplan, L
AU  - Chen, W
TI  -  American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
J2  - Arthritis Care Res
SP  - 1515
PY  - 2010
VL  - 62
SP  - 1515
ER  - 
TY  - JOUR
LB  - 202.
AU  - Paskins, Z
AU  - Babatunde, O
AU  - Sturrock, A
AU  - Toh, LS
AU  - Horne, R
AU  - Maidment, I
AU  - On behalf of the Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis and Bone Research Academy
TI  -  Supporting patients to get the best from their osteoporosis treatment: a rapid realist review
J2  - Osteoporos Int
SP  - 2245
PY  - 2022
VL  - 33
SP  - 2245
ER  - 
TY  - JOUR
LB  - 203.
AU  - Paskins, Z
AU  - Bullock, L
AU  - Crawford-Manning, F
AU  - Cottrell, E
AU  - Fleming, J
AU  - Leyland, S
TI  -  Improving uptake of fracture prevention drug treatments: a protocol for development of a consultation intervention (iFraP-D)
J2  - BMJ Open
SP  - e048811
PY  - 2021
VL  - 11
SP  - e048811
ER  - 
TY  - JOUR
LB  - 204.
AU  - Cornelissen, D
AU  - Boonen, A
AU  - Evers, S
AU  - van den Bergh, JP
AU  - Bours, S
AU  - Wyers, CE
TI  -  Improvement of osteoporosis Care Organized by Nurses: ICON study – protocol of a quasi-experimental study to assess the (cost)-effectiveness of combining a decision aid with motivational interviewing for improving medication persistence in patients with a recent fracture being treated at the fracture liaison service
J2  - BMC Musculoskelet Disord
SP  - 913
PY  - 2021
VL  - 22
SP  - 913
ER  - 
TY  - JOUR
LB  - 205.
AU  - Sale, J
AU  - Marwah, A
AU  - Naeem, F
AU  - Yu, W
AU  - Meadows, L
TI  -  Evidence of patient beliefs, values, and preferences is not provided in osteoporosis clinical practice guidelines
J2  - Osteoporos Int
SP  - 1325
PY  - 2019
VL  - 30
SP  - 1325
ER  -